Cargando…

Clinical Tolerogenic Dendritic Cells: Exploring Therapeutic Impact on Human Autoimmune Disease

Tolerogenic dendritic cell (tDC)-based clinical trials for the treatment of autoimmune diseases are now a reality. Clinical trials are currently exploring the effectiveness of tDC to treat autoimmune diseases of type 1 diabetes mellitus, rheumatoid arthritis, multiple sclerosis (MS), and Crohn’s dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Phillips, Brett Eugene, Garciafigueroa, Yesica, Trucco, Massimo, Giannoukakis, Nick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643419/ https://www.ncbi.nlm.nih.gov/pubmed/29075262 http://dx.doi.org/10.3389/fimmu.2017.01279

Ejemplares similares

Tolerogenic Dendritic Cells and T-Regulatory Cells at the Clinical Trials Crossroad for the Treatment of Autoimmune Disease; Emphasis on Type 1 Diabetes Therapy
por: Phillips, Brett Eugene, et al.
Publicado: (2019)

Co-Stimulation-Impaired Bone Marrow-Derived Dendritic Cells Prevent Dextran Sodium Sulfate-Induced Colitis in Mice
por: Engman, Carl, et al.
Publicado: (2018)

Arrest in the Progression of Type 1 Diabetes at the Mid-Stage of Insulitic Autoimmunity Using an Autoantigen-Decorated All-trans Retinoic Acid and Transforming Growth Factor Beta-1 Single Microparticle Formulation
por: Phillips, Brett E., et al.
Publicado: (2021)

Neutrophil-Associated Inflammatory Changes in the Pre-Diabetic Pancreas of Early-Age NOD Mice
por: Garciafigueroa, Yesica, et al.
Publicado: (2021)

Phase I (Safety) Study of Autologous Tolerogenic Dendritic Cells in Type 1 Diabetic Patients
por: Giannoukakis, Nick, et al.
Publicado: (2011)

Tolerogenic dendritic cells in type 1 diabetes: no longer a concept
por: Giannoukakis, Nick
Publicado: (2023)

Involvement of Suppressive B-Lymphocytes in the Mechanism of Tolerogenic Dendritic Cell Reversal of Type 1 Diabetes in NOD Mice
por: Di Caro, Valentina, et al.
Publicado: (2014)

Improvement in insulin sensitivity and prevention of high fat diet-induced liver pathology using a CXCR2 antagonist
por: Phillips, Brett E., et al.
Publicado: (2022)

Tolerogenic and Activatory Plasmacytoid Dendritic Cells in Autoimmunity
por: Guéry, Leslie, et al.
Publicado: (2013)

Current State of Type 1 Diabetes Immunotherapy: Incremental Advances, Huge Leaps, or More of the Same?
por: Phillips, Brett, et al.
Publicado: (2011)

Fluorine labelling of therapeutic human tolerogenic dendritic cells for (19)F-magnetic resonance imaging
por: Cooke, Fiona, et al.
Publicado: (2022)

Regulatory Multitasking of Tolerogenic Dendritic Cells – Lessons Taken from Vitamin D3-Treated Tolerogenic Dendritic Cells
por: Nikolic, Tatjana, et al.
Publicado: (2013)

Costimulatory Molecules on Immunogenic Versus Tolerogenic Human Dendritic Cells
por: Hubo, Mario, et al.
Publicado: (2013)

Ethyl Pyruvate Induces Tolerogenic Dendritic Cells
por: Djedovic, Neda, et al.
Publicado: (2019)

Exploring the Immunomodulatory Moonlighting Activities of Acute Phase Proteins for Tolerogenic Dendritic Cell Generation
por: Serrano, Inmaculada, et al.
Publicado: (2018)

Human Hemangioblast-Derived Mesenchymal Stem Cells Promote Islet Engraftment in a Minimal Islet Mass Transplantation Model in Mice
por: Bertera, Suzanne, et al.
Publicado: (2021)

Tolerogenic Dendritic Cells for Regulatory T Cell Induction in Man
por: Raker, Verena K., et al.
Publicado: (2015)

Induction of Tolerogenic Dendritic Cells by Endogenous Biomolecules: An Update
por: Švajger, Urban, et al.
Publicado: (2018)

Tolerogenic Dendritic Cells: The Pearl of Immunotherapy in Organ Transplantation
por: Zhuang, Quan, et al.
Publicado: (2020)

Tolerogenic Dendritic Cell-Based Approaches in Autoimmunity
por: Passeri, Laura, et al.
Publicado: (2021)

The nature of activatory and tolerogenic dendritic cell-derived signal II
por: Bakdash, Ghaith, et al.
Publicado: (2013)

The Nature of Activatory and Tolerogenic Dendritic Cell-Derived Signal 2
por: Granucci, Francesca, et al.
Publicado: (2014)

The Nature of Activatory and Tolerogenic Dendritic Cell-Derived Signal 2
por: Granucci, Francesca, et al.
Publicado: (2013)

Transcriptomic Analysis Identifies A Tolerogenic Dendritic Cell Signature
por: Robertson, Harry, et al.
Publicado: (2021)

Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials
por: Moreau, Aurélie, et al.
Publicado: (2012)

Tolerogenic Transcriptional Signatures of Steady-State and Pathogen-Induced Dendritic Cells
por: Vendelova, Emilia, et al.
Publicado: (2018)

Tolerance through Education: How Tolerogenic Dendritic Cells Shape Immunity
por: Domogalla, Matthias P., et al.
Publicado: (2017)

Autoimmune Inflammation and Insulin Resistance: Hallmarks So Far and Yet So Close to Explain Diabetes Endotypes
por: Petrelli, Alessandra, et al.
Publicado: (2021)

Gene Expression Profiling of Human Monocyte-derived Dendritic Cells – Searching for Molecular Regulators of Tolerogenicity
por: Schinnerling, Katina, et al.
Publicado: (2015)

Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene Transfer
por: Comi, Michela, et al.
Publicado: (2020)

Translating Mechanism of Regulatory Action of Tolerogenic Dendritic Cells to Monitoring Endpoints in Clinical Trials
por: Suwandi, Jessica S., et al.
Publicado: (2017)

Tolerogenic IDO(+) Dendritic Cells Are Induced by PD-1-Expressing Mast Cells
por: Rodrigues, Cecilia Pessoa, et al.
Publicado: (2016)

Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand?
por: Marín, Eros, et al.
Publicado: (2018)

Regulation of Tolerogenic Features on Dexamethasone-Modulated MPLA-Activated Dendritic Cells by MYC
por: García-González, Paulina A., et al.
Publicado: (2019)

Tolerogenic Dendritic Cells Reduce Cardiac Inflammation and Fibrosis in Chronic Chagas Disease
por: Santos, Emanuelle de Souza, et al.
Publicado: (2020)

Generation of Tolerogenic Dendritic Cells and Their Therapeutic Applications
por: Yoo, Seungbo, et al.
Publicado: (2016)

It’s Time to Bring Dendritic Cell Therapy to Type 1 Diabetes
por: Creusot, Rémi J., et al.
Publicado: (2014)

Phosphatidylserine-Liposomes Promote Tolerogenic Features on Dendritic Cells in Human Type 1 Diabetes by Apoptotic Mimicry
por: Rodriguez-Fernandez, Silvia, et al.
Publicado: (2018)

Corrigendum: Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene Transfer
por: Comi, Michela, et al.
Publicado: (2021)

HIV-1 induction of tolerogenic dendritic cells is mediated by cellular interaction with suppressive T cells
por: Svanberg, Cecilia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fcrm6igd91tq9cf9bucpj7ie6d